# Efficacy of Curcumin in Oral Submucous Fibrosis

> **NCT03511261** · PHASE2 · UNKNOWN · sponsor: **H.K.E.S's S.Nijalingappa Institute of Dental Science and Research** · enrollment: 200 (estimated)

## Conditions studied

- Oral Submucous Fibrosis

## Interventions

- **DRUG:** 10% Curcumin mucoadhesive gel
- **DRUG:** Curcumin capsules 500mg
- **DRUG:** 5% curcumin mucoadhesive gel + Curcumin capsules 250 mg
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT03511261
- **Lead sponsor:** H.K.E.S's S.Nijalingappa Institute of Dental Science and Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03511261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03511261, "Efficacy of Curcumin in Oral Submucous Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03511261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*